Global Peripheral Intervention Drug-Eluting Devices Market Insights and Forecast to 2026

1.1 Peripheral Intervention Drug-Eluting Devices Product Introduction

1.2 Key Market Segments in This Study

1.3 Key Manufacturers Covered: Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue in 2019

1.4 Market by Type

1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type

1.4.2 Plain Old Balloon Angioplasty (POBA)

1.4.3 Percutaneous Transluminal Angioplasty (PTA)

1.5 Market by Application

1.5.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application

1.5.2 Drug-Eluting Balloons

1.5.3 Drug-Eluting Stents

1.6 Study Objectives

1.7 Years Considered

2 Executive Summary

2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size, Estimates and Forecasts

2.1.1 Global Peripheral Intervention Drug-Eluting Devices Revenue Estimates and Forecasts 2015-2026

2.1.2 Global Peripheral Intervention Drug-Eluting Devices Production Capacity Estimates and Forecasts 2015-2026

2.1.3 Global Peripheral Intervention Drug-Eluting Devices Production Estimates and Forecasts 2015-2026

2.2 Global Peripheral Intervention Drug-Eluting Devices, Market Size by Producing Regions: 2015 VS 2020 VS 2026

2.3 Analysis of Competitive Landscape

2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

2.3.2 Global Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.3.3 Global Peripheral Intervention Drug-Eluting Devices Manufacturers Geographical Distribution

2.4 Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products

2.5 Primary Interviews with Key Peripheral Intervention Drug-Eluting Devices Players (Opinion Leaders)

3 Market Size by Manufacturers

3.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity

3.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production Capacity (2015-2020)

3.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Production (2015-2020)

3.1.3 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Production

3.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue

3.2.1 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (2015-2020)

3.2.2 Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers Market Share by Revenue (2015-2020)

3.2.3 Global Top 10 and Top 5 Companies by Peripheral Intervention Drug-Eluting Devices Revenue in 2019

3.3 Global Peripheral Intervention Drug-Eluting Devices Price by Manufacturers

3.4 Mergers & Acquisitions, Expansion Plans

4 Peripheral Intervention Drug-Eluting Devices Production by Regions

4.1 Global Peripheral Intervention Drug-Eluting Devices Historic Market Facts & Figures by Regions

4.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Production (2015-2020)

4.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Revenue (2015-2020)

4.2 North America

4.2.1 North America Peripheral Intervention Drug-Eluting Devices Production (2015-2020)

4.2.2 North America Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)

4.2.3 Key Players in North America

4.2.4 North America Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)

4.3 Europe

4.3.1 Europe Peripheral Intervention Drug-Eluting Devices Production (2015-2020)

4.3.2 Europe Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)

4.3.3 Key Players in Europe

4.3.4 Europe Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)

4.4 China

4.4.1 China Peripheral Intervention Drug-Eluting Devices Production (2015-2020)

4.4.2 China Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)

4.4.3 Key Players in China

4.4.4 China Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)

4.5 Japan

4.5.1 Japan Peripheral Intervention Drug-Eluting Devices Production (2015-2020)

4.5.2 Japan Peripheral Intervention Drug-Eluting Devices Revenue (2015-2020)

4.5.3 Key Players in Japan

4.5.4 Japan Peripheral Intervention Drug-Eluting Devices Import & Export (2015-2020)

5 Peripheral Intervention Drug-Eluting Devices Consumption by Region

5.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption

5.1.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions by Consumption (2015-2020)

5.1.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Market Share by Consumption (2015-2020)

5.2 North America

5.2.1 North America Peripheral Intervention Drug-Eluting Devices Consumption by Application

5.2.2 North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries

5.2.3 U.S.

5.2.4 Canada

5.3 Europe

5.3.1 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application

5.3.2 Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries

5.3.3 Germany

5.3.4 France

5.3.5 U.K.

5.3.6 Italy

5.3.7 Russia

5.4 Asia Pacific

5.4.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application

5.4.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions

5.4.3 China

5.4.4 Japan

5.4.5 South Korea

5.4.6 India

5.4.7 Australia

5.4.8 Taiwan

5.4.9 Indonesia

5.4.10 Thailand

5.4.11 Malaysia

5.4.12 Philippines

5.4.13 Vietnam

5.5 Central & South America

5.5.1 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Application

5.5.2 Central & South America Peripheral Intervention Drug-Eluting Devices Consumption by Country

5.5.3 Mexico

5.5.3 Brazil

5.5.3 Argentina

5.6 Middle East and Africa

5.6.1 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application

5.6.2 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries

5.6.3 Turkey

5.6.4 Saudi Arabia

5.6.5 U.A.E

6 Market Size by Type (2015-2026)

6.1 Global Peripheral Intervention Drug-Eluting Devices Market Size by Type (2015-2020)

6.1.1 Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020)

6.1.2 Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020)

6.1.3 Peripheral Intervention Drug-Eluting Devices Price by Type (2015-2020)

6.2 Global Peripheral Intervention Drug-Eluting Devices Market Forecast by Type (2021-2026)

6.2.1 Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026)

6.2.2 Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026)

6.2.3 Global Peripheral Intervention Drug-Eluting Devices Price Forecast by Type (2021-2026)

6.3 Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

7.2.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Historic Breakdown by Application (2015-2020)

7.2.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

8.1 Medtronic plc

8.1.1 Medtronic plc Corporation Information

8.1.2 Medtronic plc Overview

8.1.3 Medtronic plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.1.4 Medtronic plc Product Description

8.1.5 Medtronic plc Related Developments

8.2 Boston Scientific Corporation

8.2.1 Boston Scientific Corporation Corporation Information

8.2.2 Boston Scientific Corporation Overview

8.2.3 Boston Scientific Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.2.4 Boston Scientific Corporation Product Description

8.2.5 Boston Scientific Corporation Related Developments

8.3 Abbott Laboratories

8.3.1 Abbott Laboratories Corporation Information

8.3.2 Abbott Laboratories Overview

8.3.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.3.4 Abbott Laboratories Product Description

8.3.5 Abbott Laboratories Related Developments

8.4 Cardinal Health

8.4.1 Cardinal Health Corporation Information

8.4.2 Cardinal Health Overview

8.4.3 Cardinal Health Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.4.4 Cardinal Health Product Description

8.4.5 Cardinal Health Related Developments

8.5 B. Braun Melsungen AG

8.5.1 B. Braun Melsungen AG Corporation Information

8.5.2 B. Braun Melsungen AG Overview

8.5.3 B. Braun Melsungen AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.5.4 B. Braun Melsungen AG Product Description

8.5.5 B. Braun Melsungen AG Related Developments

8.6 Biosensors International Group Ltd.

8.6.1 Biosensors International Group Ltd. Corporation Information

8.6.2 Biosensors International Group Ltd. Overview

8.6.3 Biosensors International Group Ltd. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.6.4 Biosensors International Group Ltd. Product Description

8.6.5 Biosensors International Group Ltd. Related Developments

8.7 C.R. Bard, Inc.

8.7.1 C.R. Bard, Inc. Corporation Information

8.7.2 C.R. Bard, Inc. Overview

8.7.3 C.R. Bard, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.7.4 C.R. Bard, Inc. Product Description

8.7.5 C.R. Bard, Inc. Related Developments

8.8 Abbott

8.8.1 Abbott Corporation Information

8.8.2 Abbott Overview

8.8.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.8.4 Abbott Product Description

8.8.5 Abbott Related Developments

8.9 The Lubrizol Corporation

8.9.1 The Lubrizol Corporation Corporation Information

8.9.2 The Lubrizol Corporation Overview

8.9.3 The Lubrizol Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.9.4 The Lubrizol Corporation Product Description

8.9.5 The Lubrizol Corporation Related Developments

8.10 Terumo Corporation

8.10.1 Terumo Corporation Corporation Information

8.10.2 Terumo Corporation Overview

8.10.3 Terumo Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)

8.10.4 Terumo Corporation Product Description

8.10.5 Terumo Corporation Related Developments

9 Peripheral Intervention Drug-Eluting Devices Production Forecast by Regions

9.1 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Revenue (2021-2026)

9.2 Global Top Peripheral Intervention Drug-Eluting Devices Regions Forecast by Production (2021-2026)

9.3 Key Peripheral Intervention Drug-Eluting Devices Production Regions Forecast

9.3.1 North America

9.3.2 Europe

9.3.3 China

9.3.4 Japan

10 Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region

10.1 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

10.2 North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

10.3 Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

10.4 Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

10.5 Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

10.6 Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

11.1 Value Chain Analysis

11.2 Sales Channels Analysis

11.2.1 Peripheral Intervention Drug-Eluting Devices Sales Channels

11.2.2 Peripheral Intervention Drug-Eluting Devices Distributors

11.3 Peripheral Intervention Drug-Eluting Devices Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

12.1 Peripheral Intervention Drug-Eluting Devices Industry

12.2 Market Trends

12.3 Market Opportunities and Drivers

12.4 Market Challenges

12.5 Peripheral Intervention Drug-Eluting Devices Market Risks/Restraints

12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Peripheral Intervention Drug-Eluting Devices Study

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

Table 1. Peripheral Intervention Drug-Eluting Devices Key Market Segments in This Study

Table 2. Ranking of Global Top Peripheral Intervention Drug-Eluting Devices Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)

Table 4. Major Manufacturers of Plain Old Balloon Angioplasty (POBA)

Table 5. Major Manufacturers of Percutaneous Transluminal Angioplasty (PTA)

Table 6. Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Application 2020-2026 (K Units)

Table 7. Global Peripheral Intervention Drug-Eluting Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026

Table 8. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 9. Global Peripheral Intervention Drug-Eluting Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peripheral Intervention Drug-Eluting Devices as of 2019)

Table 10. Peripheral Intervention Drug-Eluting Devices Manufacturing Base Distribution and Headquarters

Table 11. Manufacturers Peripheral Intervention Drug-Eluting Devices Product Offered

Table 12. Date of Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market

Table 13. Key Trends for Peripheral Intervention Drug-Eluting Devices Markets & Products

Table 14. Main Points Interviewed from Key Peripheral Intervention Drug-Eluting Devices Players

Table 15. Global Peripheral Intervention Drug-Eluting Devices Production Capacity by Manufacturers (2015-2020) (K Units)

Table 16. Global Peripheral Intervention Drug-Eluting Devices Production Share by Manufacturers (2015-2020)

Table 17. Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2015-2020) (Million US$)

Table 18. Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2015-2020)

Table 19. Peripheral Intervention Drug-Eluting Devices Price by Manufacturers 2015-2020 (USD/Unit)

Table 20. Mergers & Acquisitions, Expansion Plans

Table 21. Global Peripheral Intervention Drug-Eluting Devices Production by Regions (2015-2020) (K Units)

Table 22. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Regions (2015-2020)

Table 23. Global Peripheral Intervention Drug-Eluting Devices Revenue by Regions (2015-2020) (US$ Million)

Table 24. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Regions (2015-2020)

Table 25. Key Peripheral Intervention Drug-Eluting Devices Players in North America

Table 26. Import & Export of Peripheral Intervention Drug-Eluting Devices in North America (K Units)

Table 27. Key Peripheral Intervention Drug-Eluting Devices Players in Europe

Table 28. Import & Export of Peripheral Intervention Drug-Eluting Devices in Europe (K Units)

Table 29. Key Peripheral Intervention Drug-Eluting Devices Players in China

Table 30. Import & Export of Peripheral Intervention Drug-Eluting Devices in China (K Units)

Table 31. Key Peripheral Intervention Drug-Eluting Devices Players in Japan

Table 32. Import & Export of Peripheral Intervention Drug-Eluting Devices in Japan (K Units)

Table 33. Global Peripheral Intervention Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)

Table 34. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions (2015-2020)

Table 35. North America Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)

Table 36. North America Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)

Table 37. Europe Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)

Table 38. Europe Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)

Table 39. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)

Table 40. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2015-2020) (K Units)

Table 41. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption by Regions (2015-2020) (K Units)

Table 42. Latin America Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)

Table 43. Latin America Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)

Table 44. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)

Table 45. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption by Countries (2015-2020) (K Units)

Table 46. Global Peripheral Intervention Drug-Eluting Devices Production by Type (2015-2020) (K Units)

Table 47. Global Peripheral Intervention Drug-Eluting Devices Production Share by Type (2015-2020)

Table 48. Global Peripheral Intervention Drug-Eluting Devices Revenue by Type (2015-2020) (Million US$)

Table 49. Global Peripheral Intervention Drug-Eluting Devices Revenue Share by Type (2015-2020)

Table 50. Peripheral Intervention Drug-Eluting Devices Price by Type 2015-2020 (USD/Unit)

Table 51. Global Peripheral Intervention Drug-Eluting Devices Consumption by Application (2015-2020) (K Units)

Table 52. Global Peripheral Intervention Drug-Eluting Devices Consumption Share by Application (2015-2020)

Table 53. Medtronic plc Corporation Information

Table 54. Medtronic plc Description and Major Businesses

Table 55. Medtronic plc Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 56. Medtronic plc Product

Table 57. Medtronic plc Recent Development

Table 58. Boston Scientific Corporation Corporation Information

Table 59. Boston Scientific Corporation Description and Major Businesses

Table 60. Boston Scientific Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 61. Boston Scientific Corporation Product

Table 62. Boston Scientific Corporation Recent Development

Table 63. Abbott Laboratories Corporation Information

Table 64. Abbott Laboratories Description and Major Businesses

Table 65. Abbott Laboratories Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 66. Abbott Laboratories Product

Table 67. Abbott Laboratories Recent Development

Table 68. Cardinal Health Corporation Information

Table 69. Cardinal Health Description and Major Businesses

Table 70. Cardinal Health Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 71. Cardinal Health Product

Table 72. Cardinal Health Recent Development

Table 73. B. Braun Melsungen AG Corporation Information

Table 74. B. Braun Melsungen AG Description and Major Businesses

Table 75. B. Braun Melsungen AG Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 76. B. Braun Melsungen AG Product

Table 77. B. Braun Melsungen AG Recent Development

Table 78. Biosensors International Group Ltd. Corporation Information

Table 79. Biosensors International Group Ltd. Description and Major Businesses

Table 80. Biosensors International Group Ltd. Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 81. Biosensors International Group Ltd. Product

Table 82. Biosensors International Group Ltd. Recent Development

Table 83. C.R. Bard, Inc. Corporation Information

Table 84. C.R. Bard, Inc. Description and Major Businesses

Table 85. C.R. Bard, Inc. Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 86. C.R. Bard, Inc. Product

Table 87. C.R. Bard, Inc. Recent Development

Table 88. Abbott Corporation Information

Table 89. Abbott Description and Major Businesses

Table 90. Abbott Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 91. Abbott Product

Table 92. Abbott Recent Development

Table 93. The Lubrizol Corporation Corporation Information

Table 94. The Lubrizol Corporation Description and Major Businesses

Table 95. The Lubrizol Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 96. The Lubrizol Corporation Product

Table 97. The Lubrizol Corporation Recent Development

Table 98. Terumo Corporation Corporation Information

Table 99. Terumo Corporation Description and Major Businesses

Table 100. Terumo Corporation Peripheral Intervention Drug-Eluting Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 101. Terumo Corporation Product

Table 102. Terumo Corporation Recent Development

Table 103. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Region (2021-2026) (Million US$)

Table 104. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Regions (2021-2026) (K Units)

Table 105. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type (2021-2026) (K Units)

Table 106. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Type (2021-2026) (Million US$)

Table 107. North America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 108. Europe Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 109. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 110. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 111. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions (2021-2026) (K Units)

Table 112. Peripheral Intervention Drug-Eluting Devices Distributors List

Table 113. Peripheral Intervention Drug-Eluting Devices Customers List

Table 114. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 115. Key Challenges

Table 116. Market Risks

Table 117. Research Programs/Design for This Report

Table 118. Key Data Information from Secondary Sources

Table 119. Key Data Information from Primary Sources

List of Fifures

Figure 1. Peripheral Intervention Drug-Eluting Devices Product Picture

Figure 2. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type in 2020 & 2026

Figure 3. Plain Old Balloon Angioplasty (POBA) Product Picture

Figure 4. Percutaneous Transluminal Angioplasty (PTA) Product Picture

Figure 5. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2020 & 2026

Figure 6. Drug-Eluting Balloons

Figure 7. Drug-Eluting Stents

Figure 8. Peripheral Intervention Drug-Eluting Devices Report Years Considered

Figure 9. Global Peripheral Intervention Drug-Eluting Devices Revenue 2015-2026 (Million US$)

Figure 10. Global Peripheral Intervention Drug-Eluting Devices Production Capacity 2015-2026 (K Units)

Figure 11. Global Peripheral Intervention Drug-Eluting Devices Production 2015-2026 (K Units)

Figure 12. Global Peripheral Intervention Drug-Eluting Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026

Figure 13. Peripheral Intervention Drug-Eluting Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 14. Global Peripheral Intervention Drug-Eluting Devices Production Share by Manufacturers in 2015

Figure 15. The Top 10 and Top 5 Players Market Share by Peripheral Intervention Drug-Eluting Devices Revenue in 2019

Figure 16. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Region (2015-2020)

Figure 17. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in North America (2015-2020) (K Units)

Figure 18. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)

Figure 19. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in Europe (2015-2020) (K Units)

Figure 20. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)

Figure 21. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in China (2015-2020) (K Units)

Figure 22. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in China (2015-2020) (US$ Million)

Figure 23. Peripheral Intervention Drug-Eluting Devices Production Growth Rate in Japan (2015-2020) (K Units)

Figure 24. Peripheral Intervention Drug-Eluting Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)

Figure 25. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions 2015-2020

Figure 26. North America Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 27. North America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019

Figure 28. North America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019

Figure 29. U.S. Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 30. Canada Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 31. Europe Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 32. Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019

Figure 33. Europe Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019

Figure 34. Germany Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 35. France Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 36. U.K. Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 37. Italy Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 38. Russia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 39. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)

Figure 40. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019

Figure 41. Asia Pacific Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Regions in 2019

Figure 42. China Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 43. Japan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 44. South Korea Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 45. India Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 46. Australia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 47. Taiwan Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 48. Indonesia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 49. Thailand Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 50. Malaysia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 51. Philippines Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 52. Vietnam Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 53. Latin America Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)

Figure 54. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019

Figure 55. Latin America Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019

Figure 56. Mexico Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 57. Brazil Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 58. Argentina Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 59. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (K Units)

Figure 60. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application in 2019

Figure 61. Middle East and Africa Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Countries in 2019

Figure 62. Turkey Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 63. Saudi Arabia Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 64. U.A.E Peripheral Intervention Drug-Eluting Devices Consumption and Growth Rate (2015-2020) (K Units)

Figure 65. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type (2015-2020)

Figure 66. Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type in 2019

Figure 67. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type (2015-2020)

Figure 68. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share by Type in 2019

Figure 69. Global Peripheral Intervention Drug-Eluting Devices Production Market Share Forecast by Type (2021-2026)

Figure 70. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Type (2021-2026)

Figure 71. Global Peripheral Intervention Drug-Eluting Devices Market Share by Price Range (2015-2020)

Figure 72. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share by Application (2015-2020)

Figure 73. Global Peripheral Intervention Drug-Eluting Devices Value (Consumption) Market Share by Application (2015-2020)

Figure 74. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Application (2021-2026)

Figure 75. Global Peripheral Intervention Drug-Eluting Devices Revenue Forecast by Regions (2021-2026) (US$ Million)

Figure 76. Global Peripheral Intervention Drug-Eluting Devices Revenue Market Share Forecast by Regions ((2021-2026))

Figure 77. Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Regions (2021-2026) (K Units)

Figure 78. North America Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)

Figure 79. North America Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 80. Europe Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)

Figure 81. Europe Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 82. China Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)

Figure 83. China Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 84. Japan Peripheral Intervention Drug-Eluting Devices Production Forecast (2021-2026) (K Units)

Figure 85. Japan Peripheral Intervention Drug-Eluting Devices Revenue Forecast (2021-2026) (US$ Million)

Figure 86. Global Peripheral Intervention Drug-Eluting Devices Consumption Market Share Forecast by Region (2021-2026)

Figure 87. Peripheral Intervention Drug-Eluting Devices Value Chain

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Porter's Five Forces Analysis

Figure 91. Bottom-up and Top-down Approaches for This Report

Figure 92. Data Triangulation

Figure 93. Key Executives Interviewed